Picture of Precision Peptide logo

BPC Precision Peptide Balance Sheet

0.000.00%
ca flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapSucker Stock

Annual balance sheet for Precision Peptide, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.

2021
October 31st
R2022
October 31st
2023
October 31st
2024
October 31st
2025
October 31st
Period Length:
Source:PROSPECTUSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.8080.0760.0520.140.96
Net Total Accounts Receivable
Net Total Receivables0.0840.1310.0480.0240.071
Total Inventory
Prepaid Expenses
Total Current Assets1.280.4720.1760.1821.33
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.0230.0220.0150
Net Intangible Assets
Total Assets1.340.5030.1920.1821.33
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities0.1170.2840.330.7330.401
Total Long Term Debt
Total Debt
Total Liabilities0.1170.2840.330.7330.401
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity1.230.219-0.138-0.550.93
Total Liabilities & Shareholders' Equity1.340.5030.1920.1821.33
Total Common Shares Outstanding